Less than a month after appointing a new chief executive officer, Ziopharm Oncology announced a restructure that resulted in more than 50 percent of the company’s workforce being axed.
Matthew Howes was appointed Chief Strategy Officer at The Greater Than One Group (GTO), a privately held, global marketing and communications agency with a proprietary model and focused approach leveraging data, content and media.
Fishawack Health, a leading commercialization partner for the life science industry, appointed Elizabeth (Liz) Landon to a newly created executive role as Chief People Officer.
AbelsonTaylor promoted Dave Schafer to director of digital production and quality assurance.
Imre has expanded the agency’s focus on earned activation with the addition of Bria Rooney as Vice President of Public Relations.
IPG Health CEO Dana Maiman announced that Shaheed Peera joined FCB Health Europe as Global Creative Partner. Best known as founder of the Creative Floor Awards, in addition to other countless achievements, Peera will partner with creative leaders, championing collaboration, diversity & inclusion and continued unparalleled creative excellence across the FCB Health family of agencies.
Independent agency Connelly Partners (CP) announced Sept. 13 the launch of Connelly Partners Health (CP Health), a new dedicated health practice as part of the agency’s integrated offering.
Responding to strong business growth and new consumer health assignments, AbelsonTaylor hired Kristin Glunz, a strategic brand-builder who helped expand AbelsonTaylor’s work in the consumer space during an earlier tenure with the agency, as senior account director.
Create NYC, an award-winning healthcare marketing agency, announced the promotion of Lauren Wetmore to President. As agency lead, Wetmore will optimize relationships with existing clients, develop new business opportunities and create customized strategic solutions.
AbelsonTaylor promoted Laura Paul to senior account director. According to the full-service health and wellness advertising agency, she will play a lead role in launching a novel treatment for recurrent C. difficile in the expanding area of microbiome therapeutics and will also continue as team leader on two established accounts.